Rowland Carmichael Advisors’s Dentsply Sirona XRAY Stock Holding History

Rowland Carmichael Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$615K	Sell	11,743 -844	-7%	-$41.6K	0.19%	118
2020 Q3	$550K	Sell	12,587 -194	-2%	-$8.58K	0.22%	117
2020 Q2	$563K	Sell	12,781 -955	-7%	-$40.4K	0.24%	109
2020 Q1	$533K	Buy	13,736 +5,177	+60%	+$264K	0.27%	108
2019 Q4	$484K	Sell	8,559 -784	-8%	-$43.7K	0.17%	151
2019 Q3	$498K	Sell	9,343 -775	-8%	-$41.6K	0.17%	142
2019 Q2	$590K	Sell	10,118 -3,213	-24%	-$173K	0.2%	131
2019 Q1	$661K	Sell	13,331 -2,326	-15%	-$102K	0.24%	117
2018 Q4	$583K	Sell	15,657 -2,672	-15%	-$97.2K	0.26%	104
2018 Q3	$692K	Buy	18,329 +3,857	+27%	+$161K	0.27%	98
2018 Q2	$633K	Buy	+14,472	New	+$680K	0.27%	99

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Rowland Carmichael Advisors's XRAY Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its Dentsply Sirona (XRAY) stake by 6.7% in Q4 2020, selling an estimated $41.6K and leaving 11,743 shares worth $615K. The position accounts for 0.19% of the portfolio, ranked #118.

Rowland Carmichael Advisors first reported a position in XRAY in Q2 2018 and has held it in 11 quarters since. The position peaked at $692K in Q3 2018. 532 funds tracked by Wall St. Rank hold XRAY as of Q4 2020.

Rowland Carmichael Advisors held 11,743 shares of Dentsply Sirona worth $615K as of Q4 2020.
Rowland Carmichael Advisors sold 844 Dentsply Sirona shares in Q4 2020, an estimated $41.6K.
Dentsply Sirona made up 0.19% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #118 holding.
Rowland Carmichael Advisors first reported a position in Dentsply Sirona in Q2 2018 and has held it in 11 quarters since.
Rowland Carmichael Advisors's Dentsply Sirona position peaked at $692K in Q3 2018.
532 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.